Category Archives: medicare
February 13, 2019 | Chip Kahn
Category: Affordable Care Act, FAH News, Legislation, Medicare
The so-called Medicare buy-in for those over 50 would harm more Americans than it would help. That is why we strongly oppose this legislation.
January 02, 2019 | Chip Kahn
Category: Financing, Medicare, Pharmaceuticals
The DC Federal District Court’s ruling to stop reforms to Medicare payment for drugs acquired under the 340B drug discount program is unfortunate because it undermines HHS efforts to cut drug costs and promote fairer payments.
December 21, 2018 | FAH Policy Blog Team
Today, FAH submitted comments in response to a Proposed Rule from the Centers for Medicare & Medicaid Services (CMS) making changes to the Medicare Advantage (MA) program. The FAH letter addressed support for the following policies:
November 13, 2018 | FAH Policy Blog Team
Category: Medicare, Pharmaceuticals
The Federation of American Hospitals joined 16 other groups in sending a letter to Congressional leaders today urging them to preserve the actions taken in the Bipartisan Budget Act (BBA) of 2018 to protect seniors and taxpayers from out-of-control drug prices during the upcoming lame duck session of Congress.
- Public Charge Rule Could Have Chilling Effect on Access to Care
- REPORT: A Medicare Public Option Puts Majority of Rural Hospitals at Risk
- In the News – FAH’s Study on Modernizing the HCAHPS Patient Experience Survey
- Joint Statement from National Hospitals Associations on Proposed CY 2020 OPPS Rule